Melissa A Barber Selected Research

Ly49G2 receptor

5/2008

Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Melissa A Barber Research Topics

Disease

3	Neoplasms (Cancer) 05/2008 - 01/2006
2	Leukemia 05/2008 - 01/2006
1	Lymphoma (Lymphomas) 05/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2006
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2006
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2006

Drug/Important Bio-Agent (IBA)

2	LigandsIBA 05/2008 - 01/2006
1	Ly49G2 receptorIBA 05/2008
1	CytokinesIBA 05/2007
1	Natural Killer Cell ReceptorsIBA 01/2006
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2006

Therapy/Procedure

1	Therapeutics 01/2006
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2006
1	Immunotherapy 01/2006